These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 177445)

  • 1. Receptor-active growth hormone in Laron dwarfism.
    Jacobs LS; Sneid DS; Garland JT; Laron Z; Daughaday WH
    J Clin Endocrinol Metab; 1976 Feb; 42(2):403-6. PubMed ID: 177445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue.
    Eshet R; Peleg S; Josefsberg Z; Fuchs C; Arnon R; Laron Z
    Horm Res; 1985; 22(4):276-83. PubMed ID: 3000911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism).
    Daughaday WH; Trivedi B
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4636-40. PubMed ID: 3474620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homologous IM-9 lymphocyte radioreceptor and receptor modulation assays for human serum growth hormone.
    Gavin JR; Trivedi B; Daughaday WH
    J Clin Endocrinol Metab; 1982 Jul; 55(1):133-9. PubMed ID: 6281300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defect of human growth hormone receptors in the liver of two patients with Laron-type dwarfism.
    Eshet R; Laron Z; Pertzelan A; Arnon R; Dintzman M
    Isr J Med Sci; 1984 Jan; 20(1):8-11. PubMed ID: 6321400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioreceptor-inactive growth hormone associated with stimulated secretion in normal subjects.
    Sneid DS; Jacobs LS; Weldon VV; Trivedi BL; Daughaday H
    J Clin Endocrinol Metab; 1975 Sep; 41(3):471-4. PubMed ID: 169286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum GH binding protein activities identifies the heterozygous carriers for Laron type dwarfism.
    Laron Z; Klinger B; Erster B; Silbergeld A
    Acta Endocrinol (Copenh); 1989 Oct; 121(4):603-8. PubMed ID: 2800930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dwarfism associated with normal serum growth hormone and increased bioassayable, receptorassayable, and immunoassayable somatomedin.
    Lanes R; Plotnick LP; Spencer EM; Daughaday WH; Kowarski AA
    J Clin Endocrinol Metab; 1980 Mar; 50(3):485-8. PubMed ID: 6987254
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe dwarfism with high plasma hGH levels and no somatomedin acitvity: Laron's syndrome (author's transl)].
    Mariani P; Gourmelen M; Carnot JF; Saignes F; Cayroche P
    Sem Hop; 1980 Nov 18-25; 56(43-44):1853-6. PubMed ID: 6256891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone induces insulin resistance in Laron dwarf cells via lactogenic receptors.
    Geffner ME; Bersch N; Golde DW
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1039-47. PubMed ID: 8473379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (hGH) secretion and turnover in three patients with Laron-type dwarfism.
    Keret R; Pertzelan A; Zeharia A; Zadik Z; Laron Z
    Isr J Med Sci; 1988 Feb; 24(2):75-9. PubMed ID: 3356536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of dental findings in patients with isolated growth hormone deficiency treated with human growth hormone (hGH) and in untreated patients with Laron-type dwarfism.
    Sarnat H; Kaplan I; Pertzelan A; Laron Z
    Oral Surg Oral Med Oral Pathol; 1988 Nov; 66(5):581-6. PubMed ID: 3200561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone resistance.
    Laron Z; Kowadlo-Silbergeld A; Eshet R; Pertzelan A
    Ann Clin Res; 1980 Oct; 12(5):269-77. PubMed ID: 6263171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laron dwarfism: cellular unresponsiveness to GH demonstrated on cultured lymphocytes by a cytochemical method.
    Spadoni GL; Cianfarani S; Baldini A; Ravenna L; Felli MP; Camaioni A; Manca Bitti ML; Sciré G; Boscherini B; de Capoa A
    Horm Metab Res; 1988 Jul; 20(7):450-2. PubMed ID: 3169682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of the plasma growth hormone-binding protein in Laron-type dwarfism.
    Baumann G; Shaw MA; Winter RJ
    J Clin Endocrinol Metab; 1987 Oct; 65(4):814-6. PubMed ID: 3654924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-lymphoblast cell lines from Laron dwarfs augment basal colony formation in response to extremely high concentrations of growth hormone.
    Geffner ME; Bersch N; Lippe BM; Golde DW
    J Clin Endocrinol Metab; 1990 Mar; 70(3):810-3. PubMed ID: 2307733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral unresponsiveness to human growth hormone in Laron dwarfism.
    Golde DW; Bersch N; Kaplan SA; Rimoin DL; Li CH
    N Engl J Med; 1980 Nov; 303(20):1156-9. PubMed ID: 6106895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Laron type familial dwarfism; genetic primary somatomedin deficiency].
    Pierson M; Malaprade D; Fortier G; Belleville F; Lasbennes A; Wuilbereq L
    Arch Fr Pediatr; 1978 Feb; 35(2):151-64. PubMed ID: 637670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The little women of Loja--growth hormone-receptor deficiency in an inbred population of southern Ecuador.
    Rosenbloom AL; Guevara Aguirre J; Rosenfeld RG; Fielder PJ
    N Engl J Med; 1990 Nov; 323(20):1367-74. PubMed ID: 2233903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH.
    Kowarski AA; Schneider J; Ben-Galim E; Weldon VV; Daughaday WH
    J Clin Endocrinol Metab; 1978 Aug; 47(2):461-4. PubMed ID: 263308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.